Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Washington: The Complete Guide for Women, Families, and Survivors
The journey through breast reconstruction or augmentation is often one of the most personal and challenging medical paths a woman in Washington can take. Whether you are a breast cancer survivor recovering through the Fred Hutchinson Cancer Center or a woman in Bellevue seeking revision surgery to reclaim your health, you were likely told that the materials used in your body—the acellular dermal matrix (ADM), the surgical mesh, or the bioabsorbable scaffolds—were safe, effective, and tested. We know that for many women throughout Washington, that promise has been broken.
If you are experiencing pain, swelling, infection, or a diagnosis of a rare lymphoma like BIA-ALCL, you are likely searching for answers that your surgeon may not yet be able to provide. At Attorney911, led by Managing Partner Ralph Manginello with over twenty-seven years of continuous legal practice, we have dedicated ourselves to investigating the regulatory failures and corporate shortcuts that have allowed these devices into Washington operating rooms. Together with associate attorney Lupe Peña, who provides full client consultations in fluent Spanish, our firm works to give a voice to those who have been silenced by the medical device industry.
This guide is designed to be the definitive resource for patients in Washington. We will examine the science of why these devices fail, the FDA’s recent warnings regarding products like GalaFLEX and Phasix, and the specific legal framework in Washington that allows you to seek justice. When you are ready to talk, we are here for a confidential, no-obligation conversation at 1-888-ATTY-911.
Understanding the Devices: Mesh, ADM, and Scaffolds in Washington Surgeries
To understand your legal options in Washington, it is first necessary to understand exactly what was placed in your body. In both reconstructive and aesthetic breast surgery, surgeons often use supplemental materials to support the “lower pole” of the breast or to create an “internal bra” effect. These materials generally fall into three categories.
Acellular Dermal Matrix (ADM)
ADM is a biologic material derived from human or animal skin. Common brands used in Washington hospitals include AlloDerm (Allergan/AbbVie), FlexHD (MTF Biologics), and Strattice. The manufacturing process involves removing all cells from the donor tissue, leaving behind a collagen scaffold that is intended to integrate with your own tissue. However, as Ralph Manginello and our team have researched, the sterilization of these biologic products can sometimes fail to eliminate bacterial endotoxins, leading to a condition known as Red Breast Syndrome (RBS).
Bioabsorbable Scaffolds
These are synthetic, dissolvable structures designed to provide temporary support before being absorbed by the body. The most prominent of these are the GalaFLEX and Phasix product lines, manufactured by Becton Dickinson (BD)/Bard. These are made of poly-4-hydroxybutyrate (P4HB). While marketed as being absorbed within 18 to 24 months, many Washington patients have reported that these scaffolds do not dissolve as advertised, leading to chronic inflammation or palpable, painful mesh edges years after surgery.
Synthetic Surgical Mesh
Standard permanent mesh, often made of polypropylene, was never intended for use in the delicate tissue of the breast. When used off-label in Washington surgeries, it can lead to severe tissue erosion and chronic neuropathic pain.
If you have undergone surgery in Seattle, Spokane, or Tacoma and suspect a device failure, one of the first steps our firm recommends is securing your operative report to identify the specific brand and lot number of the device used. You can contact us at 888-ATTY-911 to discuss how we can assist you in this investigative process.
The FDA Regulatory Failure: Why Washington Patients Weren’t Warned
Many patients in Washington are shocked to learn that most breast mesh and ADM products were never “approved” by the FDA for use in the breast. Instead, they reached the market through the 510(k) clearance pathway—a regulatory “shortcut” that allows devices to be sold if they are “substantially equivalent” to a product already on the market.
Under 21 CFR §807.92, manufacturers only need to show a similarity to a “predicate device.” This has led to what we call “predicate creep.” For example, the GalaFLEX scaffold used in many Washington breast lifts was cleared based on its similarity to a surgical suture. This means it was never clinicaly tested in breast tissue before it was marketed to your surgeon.
The November 2023 FDA Labeling Update
In a critical move for Washington litigants, the FDA issued a letter on November 9, 2023, specifically addressing BD/Bard mesh products. The FDA stated verbatim: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” This letter required BD to update the labels for Phasix and GalaFLEX products to reflect this lack of data.
Ralph Manginello and Lupe Peña closely monitor these regulatory shifts. For a Washington woman, this FDA acknowledgment is powerful evidence that the manufacturer may have engaged in off-label promotion without adequate safety warnings. If you have been told your complications are “just part of the healing process,” know that the FDA’s own records suggest otherwise.
The Spectrum of Complications for Washington Patients
Complications from defective breast devices can range from aesthetic failures to life-threatening systemic illnesses. In Washington’s high-volume medical centers, we have seen patients struggle with a wide variety of symptoms following the use of ADM or P4HB scaffolds.
Oncological Concerns: BIA-ALCL and BIA-SCC
The most severe complication associated with textured implants—often used in conjunction with ADM—is Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). This is a CD30-positive, ALK-negative T-cell lymphoma recognized by the World Health Organization since 2016. Furthermore, the FDA has identified Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC), a distinct epithelial tumor that can form in the surgical capsule.
Red Breast Syndrome (RBS)
Unique to ADM products like AlloDerm or FlexHD, RBS is a non-infectious, sterile inflammatory response. Research, including studies by Nguyen et al. (2019), points to endotoxin (lipopolysaccharide) contamination as the cause. For a woman in Washington, this means your body is reacting to a biological toxin that survived the manufacturer’s sterilization process.
Mechanical and Structural Failures
- Reconstruction Failure: When the ADM fails to integrate, your body may reject the entire reconstruction, leading to a “flat closure” outcome.
- Scaffold Malposition: In Washington revision cases, we often see GalaFLEX “bottoming out,” where the scaffold fails to support the implant, leading to permanent asymmetry.
- Chronic Seroma: Persistent fluid collection around the device that may require multiple painful aspirations.
The financial and emotional toll of these injuries is immense. Research shows that a single reconstruction complication can increase a patient’s medical costs by over $7,000 in the first year alone. At Attorney911, we believe the manufacturer, not the patient, should bear this burden. Call 1-888-288-9911 to speak with our team about your experience.
Navigating the Legal Landscape in Washington
Washington has a specific and nuanced legal framework for product liability that differs significantly from other states. Understanding these laws is critical to the success of your claim.
The Washington Product Liability Act (WPLA)
Under RCW 7.72, Washington residents can hold manufacturers accountable for design defects, manufacturing defects, and the failure to provide adequate warnings. Ralph Manginello and our firm analyze these cases through the lens of RCW 7.72.030, which defines the liability of manufacturers. Our goal is to prove that the mesh or ADM used in your body was “not reasonably safe” because the manufacturer failed to warn your surgeon about its off-label risks.
Statute of Limitations and the Discovery Rule
In Washington, the statute of limitations for a product liability claim is generally three years under RCW 7.72.060. However, Washington applies a “discovery rule.” This means the clock may not begin to run until you knew or reasonably should have known that your injury was caused by the defective medical device. For many women in Washington, this “discovery” occurred only after the FDA’s November 2023 safety communication or after an explant surgery revealed the degraded state of the mesh.
Comparative Fault in Washington
Washington is a pure comparative fault state. This means that even if a defendant argues that other factors contributed to your injury, you are still entitled to recover damages reduced by your percentage of fault. In device cases, the patient is almost never at fault, as you relied on the expertise of your surgeon and the representations of the manufacturer.
Lupe Peña’s background in insurance defense provides our firm with an “insider” view of how medical device companies attempt to use Washington law to avoid liability. We use this knowledge to protect our clients from the tactics used by large corporate legal teams.
Why Washington Women Choose Attorney911
When you are facing a multi-billion-dollar manufacturer like Becton Dickinson or Allergan, the firm you choose matters. Generalist personal injury firms often lack the scientific depth to understand BIA-ALCL pathology or the regulatory nuances of 510(k) “predicate creep.”
Proven complex litigation experience
We are currently lead counsel in Bermudez v. Pi Kappa Phi Fraternity, Inc., et al., a high-profile $10,000,000 institutional liability case filed in November 2025. This experience in managing multi-defendant, complex litigation is directly applicable to the structure of medical device lawsuits, which often involve the manufacturer, distributors, and multiple corporate entities.
Verifiable credentials and third-party recognition
Ralph Manginello holds an Avvo “Excellent” 8.2 rating and has been Peer Review Rated by Martindale-Hubbell. Our firm maintains near-perfect ratings across Birdeye and the Better Business Bureau. These aren’t just badges; they represent hundreds of families we have helped through their most difficult moments.
Bilingual representation with Lupe Peña
Washington’s vibrant Hispanic and Latino communities deserve legal representation without a language barrier. Lupe Peña conducts full consultations in Spanish, ensuring that nothing is lost in translation when discussing your medical history or your legal rights. Hablamos español, and we are ready to listen.
If you are a resident of Seattle, Spokane, Tacoma, Vancouver, or Bellevue, our team has the federal court admissions—including admission to the United States District Court—necessary to prosecute your case in the appropriate venue. Call us at 1-888-ATTY-911 for a free evaluation.
The Allergan BIOCELL MDL 2921 and Current Litigation Status
While many individual breast mesh cases are filed separately, the litigation regarding Allergan BIOCELL textured implants has been consolidated into Multidistrict Litigation (MDL 2921) in the District of New Jersey under Judge Brian R. Martinotti.
For Washington patients with these specific implants, this MDL is a critical pathway to recovery. A bellwether trial is currently scheduled for October 19, 2026. Bellwether trials serve as “test cases” that help both sides understand how a jury will react to the evidence. The outcomes of these trials often drive the global settlement values for all women in the MDL.
Regarding GalaFLEX and other P4HB scaffolds, litigation is emerging rapidly. The first wave of GalaFLEX cases has been filed in Rhode Island, where BD’s surgical mesh headquarters are located. These lawsuits allege that the devices caused chronic pain and did not dissolve as promised. Ralph Manginello and our team are actively reviewing new GalaFLEX and Phasix claims from Washington every day.
The Whistleblower Perspective: Dr. Hooman Noorchashm
At Attorney911, we believe in bringing every piece of evidence to light. Washington patients should be aware of the testimony of Dr. Hooman Noorchashm, a cardiothoracic surgeon and former Medical Director at Becton Dickinson. Dr. Noorchashm was terminated in 2022 after raising internal safety concerns about GalaFLEX.
His allegations are chilling: he asserts that BD withheld data concerning breast cancer recurrences in GalaFLEX clinical trials from the FDA. He has filed formal citizen petitions urging the FDA to stop the off-label marketing of these devices in breast surgery. When you work with us, we incorporate this “insider” evidence to show that the manufacturer’s failure to warn was not an accident—it was a corporate choice.
Evidence Checklist: What Every Washington Patient Needs
To build a strong case under the Washington Product Liability Act, documentation is your greatest asset. We recommend Washington patients take the following steps:
- Request your Operative Report: This is different from your discharge summary. It contains the “implant log” where the surgeon recorded the UDI (Unique Device Identifier) and lot numbers.
- Preserve the Explanted Device: If you are undergoing revision or explant surgery, your attorney must send a “preservation letter” to the hospital or surgical center. In Washington, hospitals often destroy biomedical waste quickly; we must act to ensure that the mesh or scaffold is preserved for independent pathological analysis.
- Secure Pathology Slides: If a biopsy was performed to check for BIA-ALCL or BIA-SCC, those slides are evidence of the cellular changes caused by the device.
- Document Financial Hardship: Medical device injuries in Washington lead to significant out-of-pocket costs. Save every bill and pharmacy receipt.
Ralph Manginello and the team at Attorney911 can guide you through the process of secure record collection. We handle the heavy lifting so you can focus on your recovery.
Frequently Asked Questions for Washington Residents
Is surgical mesh actually illegal in breast surgery?
No, it is not “illegal,” but it is “off-label.” Surgeons can use products in ways not cleared by the FDA, but manufacturers cannot market them for those uses. The FDA confirmed in 2023 that no surgical mesh is approved for breast surgery.
I had my surgery at a top center in Seattle ten years ago. Is it too late to sue?
Not necessarily. Under Washington’s discovery rule, the 3-year statute of limitations may not start until you connected your injury to the device. Many women are only now discovering this link.
What if I can’t afford an attorney?
We operate on a contingency fee basis. This means there is no upfront cost to you. We only receive a fee if we successfully recover compensation on your behalf. We represent victims in Washington regardless of their financial status.
How long will my case take?
Device litigation is complex. While individual settlements can sometimes be reached faster, cases involved in an MDL or coordinated proceeding can take several years. We provide regular updates to ensure you are never in the dark about your case status.
Can I sue if I have “Breast Implant Illness” (BII)?
Yes. While BII is still being researched by the FDA, thousands of women have reported systemic symptoms like fatigue and joint pain. We evaluate these cases on an individual basis, looking for evidence of manufacturer concealment of these systemic risks.
Your Path Forward: Seeking Justice in Washington
The specialized medical communities in Washington—from the plastic surgery clinics in Bellevue to the oncology units in Spokane—are among the best in the world. However, even the most skilled surgeon is limited by the safety and honesty of the tools provided by manufacturers. When those tools are defective, the law provides a way to hold the corporations responsible.
At Attorney911, we believe that every woman in Washington deserves to be treated with dignity, transparency, and a high standard of care. Ralph Manginello and Lupe Peña are here to ensure that your story is heard and that your injuries are compensated. We invite you to join our community of advocates and survivors.
Do not allow a statute of limitations to expire while you wait for answers. Let us help you find the truth about what was placed in your body and what the manufacturer knew.
Contact Attorney911 today.
Call 1-888-ATTY-911 (1-888-288-9911) for a free, confidential consultation.
Visit us online at attorney911.com to learn more about our team and our commitment to justice for Washington families.
Your health is your most valuable asset. We are here to help you protect it.
Disclaimer: This content is for educational purposes only and does not constitute legal advice. Past results do not guarantee future outcomes. The Manginello Law Firm, PLLC is a Texas-based firm practicing nationwide in federal courts. Case expenses may apply. No fee unless we recover compensation for you.
